Exponent
Engineering and scientific consulting for product safety, failures, disputes, health, and environmental risk.
Something off on this page? Send us feedback.
Profile
Provides project-based engineering and scientific consulting across failure investigation, product development and testing, infrastructure, environmental risk, health, and chemical regulation. Professional fees from multidisciplinary engagements drive revenue, while demand depends on client project timing, litigation and regulation, and access to specialized technical staff.
Provides project-based engineering and scientific consulting through Engineering and Other Scientific and Environmental and Health. Work spans biomechanics, civil and construction, data and electrical systems, materials and mechanical engineering, vehicle testing, chemical regulation and food safety, ecology, and human-health risk.
Multidisciplinary teams investigate accidents and product failures, test designs, assess safety and reliability, support product development and regulatory submissions, and supply technical analysis for disputes. Revenue comes mainly from professional fees, with equipment use and reimbursed outside expenses contributing less. Operations are centered in the United States, with offices in Europe and Asia.
Demand depends on engagement timing, litigation and regulatory activity, and retaining specialized staff; engagements are project-based and client-terminable, leaving little backlog.
Company facts
Categories
Key statistics
Year to date +2.0% · Average volume (30d) 477.5K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | UBS | Reiterate | Neutral | $75 | $72 | |
| Jun 2, 2026 | UBS | Target | $85 | $75 | ||
| Feb 9, 2026 | UBS | Target | $81 | $85 | ||
| Dec 15, 2025 | UBS | Reiterate | Neutral | $88 | $81 | |
| Nov 17, 2025 | William Blair | Upgrade | Market Perform | Outperform |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 30, 2026Q2 FY26 | $0.55 | $0.60 | +9.3% | $145.0M | $148.9M | +2.7% | +3.53% |
| Apr 30, 2026Q1 FY26 | $0.56 | $0.59 | +5.4% | $149.5M | $151.8M | +1.5% | −2.41% |
| Feb 5, 2026Q4 FY25 | $0.47 | $0.49 | +4.3% | $128.1M | $129.4M | +1.0% | +12.65% |
| Oct 30, 2025Q3 FY25 | $0.50 | $0.55 | +10.0% | $128.5M | $147.1M | +14.5% | +5.97% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $145.5M | $142.0M | $147.1M | $147.4M | $166.3M | $171.6M | |
| Gross profit | $137.4M | $23.3M | $36.7M | $35.9M | $47.6M | $35.4M | |
| Operating income | $44.4M | $17.2M | $29.0M | $29.1M | $41.4M | $28.0M | |
| Net income | $26.7M | $26.6M | $28.0M | $24.8M | $29.6M | $29.4M | |
| Diluted EPS | $0.52 | $0.52 | $0.55 | $0.49 | $0.59 | $0.60 | |
| Gross margin | 94.5% | 16.4% | 24.9% | 24.3% | 28.6% | 20.6% | |
| Operating margin | 30.5% | 12.1% | 19.7% | 19.8% | 24.9% | 16.3% |
Fiscal years (4-quarter sums)FY21 $434.9M · FY22 $463.8M · FY23 $506.2M · FY24 $550.8M · FY25 $582.0M
Revenue by product · Q2 FY26
Revenue by geography · FY25
Balance sheet, Jul 3, 2026Cash & short-term investments $66.6M · Total debt $80.7M · Total assets $652.7M · Shareholders' equity $288.6M
Dividends
Raised for 12 straight years — most recently to $0.31 from $0.30 in Mar 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 5, 2026 | Jun 5 | Jun 18 | $0.31 | |
| Mar 6, 2026 | Mar 6 | Mar 20 | $0.31 | raised from $0.30 |
| Dec 5, 2025 | Dec 5 | Dec 19 | $0.30 | |
| Sep 5, 2025 | Sep 5 | Sep 19 | $0.30 | |
| Jun 6, 2025 | Jun 6 | Jun 20 | $0.30 | |
| Mar 7, 2025 | Mar 7 | Mar 21 | $0.30 | raised from $0.28 |
| Dec 6, 2024 | Dec 6 | Dec 20 | $0.28 | |
| Sep 6, 2024 | Sep 6 | Sep 20 | $0.28 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 48.51M · Float 47.93M · 98.8% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 6.18M | 12.75% | 13F | Aug 7, 2026 |
| Kayne Anderson Rudnick Investment Management LLC | 4.00M | 8.24% | 13F | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 3.14M | 6.48% | 13F | Aug 13, 2026 |
| Vanguard Capital Management LLC | 2.18M | 4.49% | 13F | Aug 13, 2026 |
| State Street Corp | 1.94M | 4.01% | 13F | Aug 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | Catherine Corrigan | director, officer: Chief Executive Officer | −1,707 | $66.28 |
| Jul 15, 2026 | Catherine Corrigan | director, officer: Chief Executive Officer | −1,737 | $62.78 |
| Jun 15, 2026 | Catherine Corrigan | director, officer: President & CEO | −4,119 | $57.13 |
| May 26, 2026 | Bradley A. James | officer: Group Vice President | −2,000 | $57.47 |
| May 19, 2026 | Richard Reiss | officer: Group Vice President | −1,672 | $58.65 |
Peers
- Tetra Tech
High-end engineering and environmental consulting overlap
- AECOM
Large-scale engineering, advisory, and EHS consulting rival
- Jacobs Solutions
Infrastructure, environmental, water, and life-science consulting peer
- Stantec
Sustainable engineering and environmental consulting competitor
- ICF
Energy, environment, disaster recovery, and health consulting overlap
- FTI Consulting
Forensic, litigation, investigations, and expert-consulting overlap
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Exponent | $71.53 | −0.03% | $3.47B | 32.1 | 29.3 | 5.5 | +4.9% |
| Tetra Tech | $36.54 | 0.00% | $9.48B | 22.0 | 21.6 | 1.9 | −19.0% |
| AECOM | $69.38 | +0.29% | $8.89B | 31.7 | 11.2 | 0.6 | −61.5% |
| Jacobs Solutions | $151.98 | −0.01% | $17.95B | 53.3 | 18.9 | 1.3 | −20.2% |
| Stantec | $75.10 | +0.40% | $8.53B | 23.4 | 22.1 | 1.5 | −13.1% |
| ICF | $90.22 | +0.03% | $1.63B | 18.7 | 12.1 | 0.9 | −0.4% |
| FTI Consulting | $153.74 | −0.06% | $4.25B | 19.0 | 14.8 | 1.1 | +5.3% |
| Median | 22.7 | 16.9 | 1.2 | −16.0% |